Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,809 | -3,622 | -13,239 | -9,411 | -6,397 |
| Depreciation Amortization | 66 | 33 | 1,758 | 50 | 34 |
| Other Working Capital | 735 | 549 | -569 | 210 | 237 |
| Other Operating Activity | 539 | 225 | 608 | 453 | 396 |
| Operating Cash Flow | $-5,468 | $-2,815 | $-11,442 | $-8,699 | $-5,730 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -6 | -330 | 44 | -1 |
| Investing Cash Flow | $-16 | $-6 | $-330 | $44 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | -1 | -3 | -2 | -2 |
| Common Stock Issued | 9,025 | N/A | N/A | 9,076 | N/A |
| Other Financing Activity | 0 | 0 | 15,024 | 5,949 | -93 |
| Financing Cash Flow | $9,023 | $-1 | $15,021 | $15,022 | $-95 |
| Beginning Cash Position | 13,311 | 13,311 | 10,061 | 10,061 | 10,061 |
| End Cash Position | 16,850 | 10,488 | 13,311 | 16,429 | 4,236 |
| Net Cash Flow | $3,539 | $-2,822 | $3,249 | $6,367 | $-5,826 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,468 | -2,815 | -11,442 | -8,699 | -5,730 |
| Capital Expenditure | -16 | -6 | -385 | -1 | -1 |
| Free Cash Flow | -5,484 | -2,822 | -11,827 | -8,700 | -5,731 |